Zurcher Kantonalbank »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Zurcher Kantonalbank

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Zurcher Kantonalbank from 13F filings

Historical chart of Zurcher Kantonalbank investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Zurcher Kantonalbank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Zurcher Kantonalbank

Quarter filed Position value Share count Share price at filing
2024-12-31 $717k 650k 1.10
2024-09-30 $498k 450k 1.11
2024-06-30 $969k 750k 1.29
2024-03-31 $756k 650k 1.16
2023-12-31 $759k 750k 1.01
2023-09-30 $845k 750k 1.13

More positions owned by Zurcher Kantonalbank

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ubs Group SHS (UBS)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alcon Ord Shs (ALC)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Procter & Gamble Company (PG)

View all positions for Zurcher Kantonalbank

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Linden Advisors
Advent Capital Management
Calamos Advisors
Highbridge Capital Management
Tenor Capital Management
Davidson Kempner Capital Management
Bank Of Montreal
Lazard Asset Management
Magnetar Financial
State Street Corporation
Bank of America Corporation
Millennium Management
Point72 Asset Management
FMR

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1